Close Menu

Molecular Detection

Bioneer has been awarded US Patent No. 8,513,399, "Primers for PCR amplification comprising basic parts within the primer sequences."
Hyun Bae Kim, Seong Youl Kim, Jun Mo Gil, Hae Joon Park, and Han Oh Park are named as inventors.

Roche last week said that it has received US Food and Drug Administration approval of a new pre-analytical instrument that integrates primary tube handling into its Cobas molecular testing platform.

By Ben Butkus
Molecular Detection said this week that it has completed a $1.5 million financing to advance commercialization of its Detect-Ready molecular diagnostic panels for detecting sepsis and gastrointestinal diseases.

NEW YORK (GenomeWeb News) – Molecular diagnostic firm Molecular Detection today said that it has completed a $1.5 million financing round to advance its tests for detecting sepsis and gastrointestinal diseases.

NetBio has been awarded US Patent No. 8,018,593, "Integrated nucleic acid analysis."
Eugene Tan, Heung Lam, Valery Bogdanov, Gregory Kellogg, John Wright, Ulrich Thomann, and Richard Selden are named as inventors on the patent.

MDI's Detect-Ready MRSA panel is the only marketed PCR-based screen proven to be able to discriminate between MRSA, MSSA, and other related bacteria, the firm said.

Detect-Ready MRSA is a qualitative real-time PCR in vitro diagnostic test marketed in the European Union and Australia and in late-stage development in the US.

The company's test, called Detect-Ready, uses real-time PCR to amplify and evaluate multiple gene targets to detect and distinguish between samples containing MRSA, MSSA, and mixed populations of bacteria.

Molecular Detection's Detect-Ready MRSA Panel, Idaho Technology's FilmArray Respiratory Panel, Seegene's Magicplex RV Panel Real-time Test

Pages

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.